Vaccinex, Inc. (VCNX)
OTCMKTS · Delayed Price · Currency is USD
1.000
0.00 (0.00%)
May 26, 2026, 1:19 PM EST
Vaccinex Market Cap
Vaccinex has a market cap or net worth of $2.81 million as of May 27, 2026. Its market cap has decreased by -12.50% in one year.
Market Cap
2.81M
Enterprise Value
3.39M
Revenue
601.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.00
Market Cap Chart
Since August 9, 2018, Vaccinex's market cap has decreased from 130.58M to 2.81M, a decrease of -97.85%. That is a compound annual growth rate of -38.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 26, 2026 | 2.81M | -2.37% |
| Dec 31, 2025 | 2.88M | 9.74% |
| Dec 31, 2024 | 2.62M | -68.42% |
| Dec 29, 2023 | 8.31M | -74.16% |
| Dec 30, 2022 | 32.15M | 0.35% |
| Dec 31, 2021 | 32.03M | -30.87% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Aug 9, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Adaptimmune Therapeutics | 3.18M |
| Eastgate Biotech | 3.17M |
| Iterum Therapeutics | 2.91M |
| LakeShore Biopharma | 2.88M |
| ProtoKinetix | 2.74M |
| Eloxx Pharmaceuticals | 2.73M |
| Hepion Pharmaceuticals | 2.56M |
| Enzolytics | 2.42M |